Enrich Biosystems Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$4.44M
- Investors
-
15
Enrich Biosystems General Information
Description
Developer of a novel single-cell isolation technology designed to enhance biomedical research at a true single-cell level. The company's technology uses non-fluidics, dissolvable microwells and visual enrichment strategies to eliminate insurmountable pain points from existing technologies, enabling healthcare professionals to get a streamlined workflow of cell culturing, kinetics profiling and guided capturing based on cell functions.
Contact Information
Website
www.enrichbiosystems.comCorporate Office
- 21 Business Park Drive
- Suite 4
- Branford, CT 06405
- United States
Corporate Office
- 21 Business Park Drive
- Suite 4
- Branford, CT 06405
- United States
Enrich Biosystems Timeline
Enrich Biosystems Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Seed Round | 26-Nov-2025 | $4.44M | Completed | Generating Revenue | ||
| 10. Accelerator/Incubator | 30-Sep-2023 | Completed | Generating Revenue | |||
| 9. Seed Round | 16-May-2022 | Completed | Generating Revenue | |||
| 8. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 30-May-2021 | Completed | Generating Revenue | |||
| 6. Grant | 21-Aug-2020 | Completed | Generating Revenue | |||
| 5. Grant | 14-Aug-2020 | Completed | Generating Revenue | |||
| 4. Seed Round | 11-May-2020 | Completed | Generating Revenue | |||
| 3. Grant | 01-Sep-2019 | $225K | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 01-Jan-2019 | Completed | Product In Beta Test |
Enrich Biosystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Enrich Biosystems Comparisons
Industry
Financing
Details
Enrich Biosystems Competitors (47)
One of Enrich Biosystems’s 47 competitors is bit.bio, a Venture Capital-Backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| bit.bio | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| CD Genomics | Corporation | Shirley, NY | ||||
| Novus Biologicals | Formerly PE-Backed | Centennial, CO | ||||
| LevitasBio | Venture Capital-Backed | Hayward, CA | ||||
| MatTek | Corporate Backed or Acquired | Ashland, MA |
Enrich Biosystems Patents
Enrich Biosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023239895-A1 | Methods of reducing noise and ambiguity in single cell analysis | Inactive | 09-Jun-2022 | ||
| EP-4319918-A1 | Destructible microwell arrays for particle separation and analysis | Pending | 02-May-2021 | ||
| EP-4319918-A4 | Destructible microwell arrays for particle separation and analysis | Pending | 02-May-2021 | ||
| US-20240191183-A1 | Destructible microwell arrays for particle separation and analysis | Pending | 02-May-2021 | ||
| WO-2022235507-A1 | Destructible microwell arrays for particle separation and analysis | Inactive | 02-May-2021 | C12N5/0068 |
Enrich Biosystems Signals
Enrich Biosystems Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aimers Venture Partners | Venture Capital | Minority | ||
| Massachusetts Biomedical Initiatives | Accelerator/Incubator | |||
| Decent Capital | Family Office | Minority | ||
| Elm Street Ventures | VC-Backed Company | Minority | ||
| Taihill Venture | Venture Capital | Minority |
Enrich Biosystems FAQs
-
When was Enrich Biosystems founded?
Enrich Biosystems was founded in 2018.
-
Where is Enrich Biosystems headquartered?
Enrich Biosystems is headquartered in Branford, CT.
-
What is the size of Enrich Biosystems?
Enrich Biosystems has 14 total employees.
-
What industry is Enrich Biosystems in?
Enrich Biosystems’s primary industry is Biotechnology.
-
Is Enrich Biosystems a private or public company?
Enrich Biosystems is a Private company.
-
What is Enrich Biosystems’s current revenue?
The current revenue for Enrich Biosystems is .
-
How much funding has Enrich Biosystems raised over time?
Enrich Biosystems has raised $8.64M.
-
Who are Enrich Biosystems’s investors?
Aimers Venture Partners, Massachusetts Biomedical Initiatives, Decent Capital, Elm Street Ventures, and Taihill Venture are 5 of 15 investors who have invested in Enrich Biosystems.
-
Who are Enrich Biosystems’s competitors?
bit.bio, CD Genomics, Novus Biologicals, LevitasBio, and MatTek are some of the 47 competitors of Enrich Biosystems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process